"Once the facility is operating at full capacity, it is expected to assume an increasing responsibility for packaging the entire line of marketed products in the U.S., as well as perform compounding operations for select products."
Like the phrase "perform compounding operations for select products."
This facility will possible out perform GSK facility in Scottland. I recall GSK spending $5m during the pandemic to upgade the capacity of that facility to produce the Relenza compound
OW
BTA Price at posting:
$1.29 Sentiment: Buy Disclosure: Held
